Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 11.26B | $ 10.55B | $ 11.28B | $ 11.64B | $ 12.27B |
Total Assets | $ 20.32B | $ 19.20B | $ 19.66B | $ 17.74B | $ 17.18B |
Total Debt | $ 88.23M | $ 135.41M | $ 67.83M | $ 37.74M | $ 47.20M |
Net Debt | $ -11.17B | $ -10.41B | $ -11.22B | $ -11.60B | $ -12.22B |
Total Liabilities | - | - | - | - | - |
Stockholders Equity | $ 14.94B | $ 14.10B | $ 14.07B | $ 14.30B | $ 14.47B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |